• / Free eNewsletters & Magazine
  • / My Account
Home>Search Results

Related Content

  1. Videos
  2. Articles
  1. Cost-Cutting Boosting Pharma Earnings

    Big pharmaceutical companies are getting lean in an attempt to boost profitability before they lose patent protection on several important drugs, says Morningstar's Damien Conover.

  2. Big Pharma Dividends Alive and Well

    Pharmaceutical firms' lower-than-historical valuations and high-margin, patent-protected products are positive signs for investors seeking more yield.

  3. Greek Gods, Natural Gas, Browsers, and Bernanke

    Morningstar markets editor Jeremy Glaser on Exxon-XTO, a Big Fat Greek Deficit, Microsoft's EU settlement, and the Fed's familiar refrain.

  4. Why J&J Bought a Big Piece of Elan

    Morningstar's Damien Conover and Alex Morozov discuss what J&J's stake in biotech Elan means for both companies.

  1. Latin America: Europe’s Pillar of Strength

    This article is for informational purposes only. This article is not intended to provide tax, legal, insurance or other investment advice. Unless otherwise specified, you are solely responsible for determining whether any investment, security or other product or service is appropriate for you based ...

  2. What Next For The Euro-Zone?

     

  3. Future of the Eurozone

    We have a position in securities mentioned in this article but that may change at anytime. We use or best efforts to obtain good data, however it can’t be guaranteed that our inputs and data are correct. This is not a recommendation for readers to purchase the securities mentioned without ...

  4. Is a more integrated Europe the answer?

    Opinions and statements of financial market trends that are based on current market conditions constitute our judgment and are subject to change without notice. We believe the information provided here is reliable but should not be assumed to be accurate or complete. The views and strategies ...

1
ShareEmail
Print
Text Size
Comment
blog comments powered by Disqus
Our Products
Tools
Resources
Services
Upcoming Events
Conferences
Webinars

©2012 Morningstar Advisor. All right reserved.